SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000320017-15-000082
Filing Date
2015-12-23
Accepted
2015-12-23 09:14:17
Documents
3
Period of Report
2015-12-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 12.23.15 a8-k122315.htm 8-K 34535
2 EXHIBIT 10.1 exhibit101rsconsultingagre.htm EX-10.1 84656
3 EXHIBIT 10.2 exhibit102bp.htm EX-10.2 124387
  Complete submission text file 0000320017-15-000082.txt   245125
Mailing Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 350 NEW YORK NY 10170 212-584-4171
Caladrius Biosciences, Inc. (Filer) CIK: 0000320017 (see all company filings)

IRS No.: 222343568 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33650 | Film No.: 151304374
SIC: 8090 Services-Misc Health & Allied Services, NEC